HIGHLIGHTS
- who: Top from the Laboratory for Tumor Biology and Angiogenesis, Innsbruck Medical University, Innsbruck, Austria have published the Article: Marine compounds inhibit growth of multiple myeloma in vitro, in the Journal: (JOURNAL)
- what: Since the experiments showed no cross-resistance to bortezomib, synergies of these marine-derived compounds with established anti-MM drugs including bortezomib and IMIDs can be expected and should be evaluated.
- how: The authors identified a subset of marine compounds with strong anti-myeloma activity in vitro and in vivo. For the purpose of future clinical drug development the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.